Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

87.78 -1.52 (-1.70%)
Official Closing Price Updated: 5:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,667,063
Open 88.85
Bid (Size) 87.22 (1)
Ask (Size) 88.12 (1)
Prev. Close 89.30
Today's Range 87.24 - 88.92
52wk Range 80.48 - 101.10
Shares Outstanding 489,219,355
Dividend Yield 0.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural tear production. 
Via Benzinga
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
From Alcon Inc. Investors
Via Business Wire

Performance

YTD
+5.2%
+5.2%
1 Month
+2.8%
+2.8%
3 Month
-2.0%
-2.0%
6 Month
+5.2%
+5.2%
1 Year
-0.4%
-0.4%

More News

Read More
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Alcon Earnings Preview
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Results of 2025 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
From Alcon Inc. Investors
Via Business Wire
Earnings Scheduled For May 13, 2025
Via Benzinga
3 Stocks Upping Dividends & 1 With A 10% Special Dividend Yield
Via MarketBeat
Alcon Publishes Agenda for 2025 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter
From Alcon Inc. Investors
Via Business Wire
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
From Alcon Inc. Investors
Via Business Wire
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities
From Alcon Inc. Investors
Via Business Wire
Alcon Eyes Surgical Edge With LENSAR Buyout: Details
Via Benzinga
Alcon Agrees to Acquire LENSAR, Inc.
From Alcon Inc. Investors
Via Business Wire
Alcon to Host 2025 Capital Markets Day
From Alcon Inc. Investors
Via Business Wire
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
From Alcon Canada
Via Business Wire
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
From Alcon Inc. Investors
Via Business Wire
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
From Alcon Inc. Investors
Via Business Wire
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
From Alcon Inc. Investors
Via Business Wire
Apple To $253? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
From Alcon Inc. Investors
Via Business Wire
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga

Frequently Asked Questions

Is Alcon Inc. Ordinary Shares publicly traded?
Yes, Alcon Inc. Ordinary Shares is publicly traded.
What exchange does Alcon Inc. Ordinary Shares trade on?
Alcon Inc. Ordinary Shares trades on the New York Stock Exchange
What is the ticker symbol for Alcon Inc. Ordinary Shares?
The ticker symbol for Alcon Inc. Ordinary Shares is ALC on the New York Stock Exchange
What is the current price of Alcon Inc. Ordinary Shares?
The current price of Alcon Inc. Ordinary Shares is 87.78
When was Alcon Inc. Ordinary Shares last traded?
The last trade of Alcon Inc. Ordinary Shares was at 07/03/25 05:00 PM ET
What is the market capitalization of Alcon Inc. Ordinary Shares?
The market capitalization of Alcon Inc. Ordinary Shares is 42.94B
How many shares of Alcon Inc. Ordinary Shares are outstanding?
Alcon Inc. Ordinary Shares has 43B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.